25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

GRF (Grifols) Stock Analysis
Buy, Hold or Sell?

Let's analyze Grifols together

I guess you are interested in Grifols S.A.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Grifols’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Grifols’s Price Targets

I'm going to help you getting a better view of Grifols S.A.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Grifols S.A.

I send you an email if I find something interesting about Grifols S.A..

1. Quick Overview

1.1. Quick analysis of Grifols (30 sec.)










1.2. What can you expect buying and holding a share of Grifols? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
60.0%

What is your share worth?

Current worth
€11.03
Expected worth in 1 year
€10.87
How sure are you?
65.0%

+ What do you gain per year?

Total Gains per Share
€-0.16
Return On Investment
-1.4%

For what price can you sell your share?

Current Price per Share
€11.91
Expected price per share
€10.83 - €13.71
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Grifols (5 min.)




Live pricePrice per Share (EOD)
€11.91
Intrinsic Value Per Share
€0.53 - €15.00
Total Value Per Share
€11.56 - €26.04

2.2. Growth of Grifols (5 min.)




Is Grifols growing?

Current yearPrevious yearGrowGrow %
How rich?$8.9b$9.7b-$145.3m-1.5%

How much money is Grifols making?

Current yearPrevious yearGrowGrow %
Making money$87.9m$44.8m$43m49.0%
Net Profit Margin4.0%2.3%--

How much money comes from the company's main activities?

2.3. Financial Health of Grifols (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Grifols?

Welcome investor! Grifols's management wants to use your money to grow the business. In return you get a share of Grifols.

First you should know what it really means to hold a share of Grifols. And how you can make/lose money.

Speculation

The Price per Share of Grifols is €11.91. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Grifols.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Grifols, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €11.03. Based on the TTM, the Book Value Change Per Share is €-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.23 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Grifols.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 β‚¬% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share€% of Price per Share
Usd Eps0.201.7%0.131.1%0.070.5%0.070.6%0.100.9%0.181.5%
Usd Book Value Change Per Share-1.37-11.5%-0.05-0.4%-0.27-2.3%-0.11-0.9%0.000.0%0.201.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.060.5%0.110.9%
Usd Total Gains Per Share-1.37-11.5%-0.05-0.4%-0.27-2.3%-0.11-0.9%0.060.5%0.312.6%
Usd Price Per Share12.24-11.21-12.99-12.06-17.05-23.81-
Price to Earnings Ratio15.22-23.69-62.32-39.27-25.37-30.22-
Price-to-Total Gains Ratio-8.96-0.40--13.19-25.79--25.12--19.70-
Price to Book Ratio0.94-0.80-0.93-0.85-1.30-2.79-
Price-to-Total Gains Ratio-8.96-0.40--13.19-25.79--25.12--19.70-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share14.074091
Number of shares71
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.06
Usd Book Value Change Per Share-0.050.00
Usd Total Gains Per Share-0.050.06
Gains per Quarter (71 shares)-3.404.49
Gains per Year (71 shares)-13.6017.98
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-14-2418-08
20-27-3836-026
30-41-5255-144
40-55-6673-162
51-69-8091-180
61-82-94109-198
71-96-108127-2116
81-110-122146-2134
91-123-136164-2152
101-137-150182-2170

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%11.01.00.091.7%17.03.00.085.0%37.03.00.092.5%56.04.00.093.3%
Book Value Change Per Share2.02.00.050.0%6.06.00.050.0%9.08.03.045.0%26.011.03.065.0%40.015.05.066.7%
Dividend per Share1.00.03.025.0%3.00.09.025.0%7.00.013.035.0%24.00.016.060.0%28.00.032.046.7%
Total Gains per Share2.02.00.050.0%6.06.00.050.0%9.08.03.045.0%26.011.03.065.0%40.015.05.066.7%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Grifols S.A. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.155-0.041-96%-0.230-80%-0.090-92%-0.001-100%0.166-796%
Book Value Per Share--11.03411.909-7%11.753-6%11.974-8%11.393-3%8.921+24%
Current Ratio--2.6362.538+4%2.292+15%2.412+9%2.188+20%2.592+2%
Debt To Asset Ratio--0.6160.606+2%0.624-1%0.613+0%0.595+3%0.615+0%
Debt To Equity Ratio--2.3542.269+4%2.335+1%2.254+4%2.057+14%1.959+20%
Dividend Per Share---0.000-100%-0%0.000-100%0.054-100%0.094-100%
Enterprise Value---4476135121.300-5169866560.885+15%-5064011063.523+13%-5330765903.688+19%-1203372128.408-73%4969713861.157-190%
Eps--0.1700.109+56%0.055+209%0.056+205%0.088+93%0.151+13%
Ev To Ebitda Ratio---3.223-3.120-3%-3.636+13%-4.835+50%-2.063-36%3.985-181%
Ev To Sales Ratio---0.592-0.696+18%-0.750+27%-0.782+32%-0.174-71%1.229-148%
Free Cash Flow Per Share--0.1380.298-54%0.056+146%0.050+174%0.077+78%0.115+20%
Free Cash Flow To Equity Per Share--0.059-0.354+701%0.122-52%-0.083+240%0.061-3%0.134-56%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--15.001----------
Intrinsic Value_10Y_min--0.528----------
Intrinsic Value_1Y_max--0.613----------
Intrinsic Value_1Y_min--0.177----------
Intrinsic Value_3Y_max--2.519----------
Intrinsic Value_3Y_min--0.428----------
Intrinsic Value_5Y_max--5.244----------
Intrinsic Value_5Y_min--0.562----------
Market Cap5027302829.760-42%7127070878.7006469663939.115+10%7649201686.478-7%6996767429.646+2%9831465571.592-28%13742889186.157-48%
Net Profit Margin--0.0620.040+56%0.023+174%0.027+133%0.050+24%0.090-31%
Operating Margin--0.1760.177-1%0.142+24%0.146+20%0.142+24%0.182-3%
Operating Ratio--0.8160.813+0%0.864-6%0.853-4%0.748+9%0.763+7%
Pb Ratio1.079+13%0.9380.801+17%0.930+1%0.852+10%1.305-28%2.788-66%
Pe Ratio17.507+13%15.22123.685-36%62.324-76%39.270-61%25.374-40%30.224-50%
Price Per Share11.905+13%10.3509.480+9%10.987-6%10.197+1%14.424-28%20.144-49%
Price To Free Cash Flow Ratio21.569+13%18.75211.682+61%17.961+4%5.293+254%7.523+149%7.774+141%
Price To Total Gains Ratio-10.303-15%-8.9570.399-2347%-13.186+47%25.795-135%-25.121+180%-19.701+120%
Quick Ratio--0.9170.909+1%0.690+33%0.743+23%0.664+38%1.022-10%
Return On Assets--0.0060.004+63%0.002+241%0.002+165%0.004+53%0.008-29%
Return On Equity--0.0230.014+66%0.006+254%0.008+175%0.013+80%0.025-9%
Total Gains Per Share---1.155-0.041-96%-0.230-80%-0.090-92%0.054-2258%0.260-544%
Usd Book Value--8982536476.6009603640121.500-6%9748990133.750-8%9729087993.783-8%9218099047.760-3%7203126896.555+25%
Usd Book Value Change Per Share---1.366-0.048-96%-0.272-80%-0.107-92%-0.001-100%0.196-796%
Usd Book Value Per Share--13.04514.079-7%13.895-6%14.155-8%13.469-3%10.547+24%
Usd Dividend Per Share---0.000-100%-0%0.000-100%0.064-100%0.111-100%
Usd Enterprise Value---5291686940.401-6111816248.279+15%-5986673879.296+13%-6302031451.339+19%-1422626530.204-73%5875195726.660-190%
Usd Eps--0.2010.129+56%0.065+209%0.066+205%0.104+93%0.178+13%
Usd Free Cash Flow--112330279.600239749273.054-53%47902152.900+134%41616789.468+170%62166991.811+81%92345129.460+22%
Usd Free Cash Flow Per Share--0.1630.352-54%0.066+146%0.059+174%0.092+78%0.136+20%
Usd Free Cash Flow To Equity Per Share--0.070-0.418+701%0.144-52%-0.098+240%0.072-3%0.158-56%
Usd Market Cap5943277405.342-42%8425623192.7997648436708.821+10%9042886233.754-7%8271578455.327+2%11622758598.736-28%16246843595.875-48%
Usd Price Per Share14.074+13%12.23611.208+9%12.989-6%12.055+1%17.052-28%23.814-49%
Usd Profit--138391878.60087910756.400+57%44863307.800+208%55495522.017+149%81601709.660+70%127066875.480+9%
Usd Revenue--2235695068.2002200579590.500+2%2012885538.650+11%2040905057.883+10%1697979910.040+32%1518843892.655+47%
Usd Total Gains Per Share---1.366-0.048-96%-0.272-80%-0.106-92%0.063-2258%0.308-544%
 EOD+1 -7MRQTTM+18 -21YOY+22 -153Y+24 -155Y+17 -2210Y+15 -24

3.3 Fundamental Score

Let's check the fundamental score of Grifols S.A. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1517.507
Price to Book Ratio (EOD)Between0-11.079
Net Profit Margin (MRQ)Greater than00.062
Operating Margin (MRQ)Greater than00.176
Quick Ratio (MRQ)Greater than10.917
Current Ratio (MRQ)Greater than12.636
Debt to Asset Ratio (MRQ)Less than10.616
Debt to Equity Ratio (MRQ)Less than12.354
Return on Equity (MRQ)Greater than0.150.023
Return on Assets (MRQ)Greater than0.050.006
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Grifols S.A. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.466
Ma 20Greater thanMa 5012.140
Ma 50Greater thanMa 10012.307
Ma 100Greater thanMa 20011.042
OpenGreater thanClose12.065
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Grifols S.A.

Grifols, S.A. operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally. The company provides immunoglobulin to treat immunodeficiencies; albumin used to restore circulatory volume and protein loss in pathophysiological conditions, such as liver cirrhosis, cardiocirculatory failure, trauma, and severe burns; alpha-1 proteinase inhibitor, a plasma protein, used to treat a genetic disease known as alpha-1; factor VIII/von Willebrand factor and factor IX, clotting factors for the treatment of hemophilia A and von Willebrand's disease, as well as hemophilia B; antithrombin III to treat hereditary antithrombin deficiency; Fostamatinib, a spleen tyrosine kinase inhibitor; combination of fibrinogen and enzyme thrombin that acts as a biological sealant to control surgical bleeding; and plasma exchange with albumin used to treat Alzheimer's disease. It also markets diagnostic testing equipment, reagents, and other equipment; offers biological products and manufacturing services; and manufactures and sells plasma to third parties. In addition, the company offers Yimmugo IDP, an immunology drug; Yimmugo PTI, a hematology drug; and Prolastin vials, a pulmonology drug. Further, it develops Xembify Pre-filled syringes, Gamunex Bags, and FlexBag; Xembify Biweekly dosing, Fibrinogen, and VISTASEAL; Prolastin-C AADT and Fostamatinib; Xembify " CLL, Albumina 20% and 5%, and Trimodulin; Alfa-1 AT 15%, GRF6019, GRF6021, Aßvac402, AKST4290, and AKST4290; GIGA 2339 and GIGA564; and recIG, Alfa-1 AT - in non-cystic fibrosis bronchiectasis, and OSIG that are in pre-clinical stage. It has collaboration agreements with Canadian Blood Services to supply grains of Immunoglobulin. The company was founded in 1909 and is headquartered in Barcelona, Spain.

Fundamental data was last updated by Penke on 2025-08-22 16:00:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Grifols earns for each €1 of revenue.

  • Above 10% is considered healthy but always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 6.2%Β means thatΒ €0.06 for each €1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Grifols S.A.:

  • The MRQ is 6.2%. The company is making a profit. +1
  • The TTM is 4.0%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ6.2%TTM4.0%+2.2%
TTM4.0%YOY2.3%+1.7%
TTM4.0%5Y5.0%-1.0%
5Y5.0%10Y9.0%-4.0%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Grifols is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • 0.6% Return on Assets means thatΒ Grifols generatedΒ €0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Grifols S.A.:

  • The MRQ is 0.6%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.4%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.6%TTM0.4%+0.2%
TTM0.4%YOY0.2%+0.2%
TTM0.4%5Y0.4%0.0%
5Y0.4%10Y0.8%-0.4%
4.3.1.3. Return on Equity

Shows how efficient Grifols is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • 2.3% Return on Equity means Grifols generated €0.02Β for eachΒ €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Grifols S.A.:

  • The MRQ is 2.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.3%TTM1.4%+0.9%
TTM1.4%YOY0.6%+0.7%
TTM1.4%5Y1.3%+0.1%
5Y1.3%10Y2.5%-1.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Grifols S.A..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Grifols is operatingΒ .

  • Measures how much profit Grifols makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • An Operating Margin of 17.6%Β means the company generated €0.18 Β for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Grifols S.A.:

  • The MRQ is 17.6%. The company is operating efficient. +1
  • The TTM is 17.7%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ17.6%TTM17.7%-0.2%
TTM17.7%YOY14.2%+3.6%
TTM17.7%5Y14.2%+3.6%
5Y14.2%10Y18.2%-4.0%
4.3.2.2. Operating Ratio

Measures how efficient Grifols is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drug Manufacturers - General industry mean).
  • An Operation Ratio of 0.82 means that the operating costs are €0.82 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Grifols S.A.:

  • The MRQ is 0.816. The company is less efficient in keeping operating costs low.
  • The TTM is 0.813. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.816TTM0.813+0.003
TTM0.813YOY0.864-0.051
TTM0.8135Y0.748+0.065
5Y0.74810Y0.763-0.015
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Grifols S.A..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Grifols is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - General industry mean).
  • A Current Ratio of 2.64Β means the company has €2.64 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Grifols S.A.:

  • The MRQ is 2.636. The company is able to pay all its short-term debts. +1
  • The TTM is 2.538. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.636TTM2.538+0.098
TTM2.538YOY2.292+0.245
TTM2.5385Y2.188+0.350
5Y2.18810Y2.592-0.404
4.4.3.2. Quick Ratio

Measures if Grifols is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.92Β means the company can pay off €0.92 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Grifols S.A.:

  • The MRQ is 0.917. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.909. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.917TTM0.909+0.008
TTM0.909YOY0.690+0.219
TTM0.9095Y0.664+0.245
5Y0.66410Y1.022-0.357
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Grifols S.A..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of GrifolsΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Grifols to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.62Β means that Grifols assets areΒ financed with 61.6% credit (debt) and the remaining percentage (100% - 61.6%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Grifols S.A.:

  • The MRQ is 0.616. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.606. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.616TTM0.606+0.010
TTM0.606YOY0.624-0.018
TTM0.6065Y0.595+0.011
5Y0.59510Y0.615-0.019
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Grifols is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 235.4% means that company has €2.35 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Grifols S.A.:

  • The MRQ is 2.354. The company is just not able to pay all its debts with equity.
  • The TTM is 2.269. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.354TTM2.269+0.085
TTM2.269YOY2.335-0.066
TTM2.2695Y2.057+0.212
5Y2.05710Y1.959+0.098
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every €1 in earnings Grifols generates.

  • Above 15 is considered overpriced butΒ always compareΒ Grifols to theΒ Drug Manufacturers - General industry mean.
  • A PE ratio of 15.22 means the investor is paying €15.22Β for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Grifols S.A.:

  • The EOD is 17.507. Based on the earnings, the company is fair priced.
  • The MRQ is 15.221. Based on the earnings, the company is fair priced.
  • The TTM is 23.685. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD17.507MRQ15.221+2.287
MRQ15.221TTM23.685-8.465
TTM23.685YOY62.324-38.639
TTM23.6855Y25.374-1.689
5Y25.37410Y30.224-4.850
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Grifols S.A.:

  • The EOD is 21.569. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 18.752. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 11.682. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD21.569MRQ18.752+2.817
MRQ18.752TTM11.682+7.070
TTM11.682YOY17.961-6.279
TTM11.6825Y7.523+4.159
5Y7.52310Y7.774-0.251
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Grifols is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 0.94 means the investor is paying €0.94Β for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Grifols S.A.:

  • The EOD is 1.079. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.938. Based on the equity, the company is cheap. +2
  • The TTM is 0.801. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.079MRQ0.938+0.141
MRQ0.938TTM0.801+0.137
TTM0.801YOY0.930-0.129
TTM0.8015Y1.305-0.504
5Y1.30510Y2.788-1.483
4.6.2. Total Gains per Share

2.4. Latest News of Grifols S.A.

Does Grifols S.A. still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Grifols S.A. to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-08-20
17:40
GRFS or NBIX: Which Is the Better Value Stock Right Now?Read
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in EUR. All numbers in thousands.

Summary
Total Assets19,767,159
Total Liabilities12,169,006
Total Stockholder Equity5,169,080
 As reported
Total Liabilities 12,169,006
Total Stockholder Equity+ 5,169,080
Total Assets = 19,767,159

Assets

Total Assets19,767,159
Total Current Assets5,246,207
Long-term Assets14,520,952
Total Current Assets
Cash And Cash Equivalents 558,691
Short-term Investments 7,109
Net Receivables 1,252,407
Inventory 3,346,864
Other Current Assets 81,136
Total Current Assets  (as reported)5,246,207
Total Current Assets  (calculated)5,246,207
+/-0
Long-term Assets
Property Plant Equipment 4,036,360
Goodwill 6,858,103
Long Term Investments 471,009
Intangible Assets 2,740,576
Long-term Assets Other 31,863
Long-term Assets  (as reported)14,520,952
Long-term Assets  (calculated)14,137,911
+/- 383,041

Liabilities & Shareholders' Equity

Total Current Liabilities1,990,152
Long-term Liabilities10,178,854
Total Stockholder Equity5,169,080
Total Current Liabilities
Short-term Debt 393,970
Short Long Term Debt 282,141
Accounts payable 878,681
Other Current Liabilities 631,434
Total Current Liabilities  (as reported)1,990,152
Total Current Liabilities  (calculated)2,186,226
+/- 196,074
Long-term Liabilities
Long term Debt 7,447,823
Capital Lease Obligations 1,089,475
Long-term Liabilities Other 692,580
Long-term Liabilities  (as reported)10,178,854
Long-term Liabilities  (calculated)9,229,878
+/- 948,976
Total Stockholder Equity
Common Stock119,604
Retained Earnings 176,786
Accumulated Other Comprehensive Income 4,094,130
Other Stockholders Equity 778,560
Total Stockholder Equity (as reported)5,169,080
Total Stockholder Equity (calculated)5,169,080
+/-0
Other
Capital Stock119,604
Cash and Short Term Investments 565,800
Common Stock Shares Outstanding 688,606
Liabilities and Stockholders Equity 19,767,159
Net Debt 8,260,748
Net Invested Capital 12,899,044
Net Working Capital 3,256,055
Property Plant and Equipment Gross 6,569,851
Short Long Term Debt Total 8,819,439



6.2. Balance Sheets Structured

Currency in EUR. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-30
> Total Assets 
0
1,888,982
0
5,344,219
5,486,724
5,807,718
5,543,025
5,912,417
5,837,321
5,627,474
5,784,323
5,846,159
5,711,151
5,841,036
7,192,367
7,276,096
8,102,746
8,449,749
9,375,155
9,095,358
9,178,563
9,601,715
9,239,045
9,539,658
9,567,865
10,129,772
11,708,358
11,116,979
11,009,939
10,920,264
10,875,229
11,433,619
11,779,675
12,477,046
13,387,065
13,323,775
14,036,984
15,542,611
15,896,382
15,597,511
15,646,913
15,274,776
16,137,599
16,213,049
0
0
0
21,039,074
0
21,533,977
21,350,830
21,432,744
22,064,498
21,454,670
21,953,010
22,291,454
20,283,644
21,405,241
20,978,557
19,767,159
19,767,15920,978,55721,405,24120,283,64422,291,45421,953,01021,454,67022,064,49821,432,74421,350,83021,533,977021,039,07400016,213,04916,137,59915,274,77615,646,91315,597,51115,896,38215,542,61114,036,98413,323,77513,387,06512,477,04611,779,67511,433,61910,875,22910,920,26411,009,93911,116,97911,708,35810,129,7729,567,8659,539,6589,239,0459,601,7159,178,5639,095,3589,375,1558,449,7498,102,7467,276,0967,192,3675,841,0365,711,1515,846,1595,784,3235,627,4745,837,3215,912,4175,543,0255,807,7185,486,7245,344,21901,888,9820
   > Total Current Assets 
0
1,144,082
0
2,109,666
1,679,898
1,929,215
1,772,920
1,896,772
1,921,424
1,934,564
1,940,745
2,039,313
1,982,701
2,139,660
2,416,613
2,412,406
2,707,671
2,913,122
2,824,727
2,751,887
2,841,230
3,089,472
2,953,273
2,920,719
2,953,073
3,122,514
2,952,170
2,851,032
2,915,714
2,945,316
2,965,872
2,947,373
3,024,376
3,483,251
3,488,966
3,424,363
3,659,798
5,362,184
3,663,767
3,554,170
3,643,616
3,164,954
3,085,574
3,239,500
5,510,280
5,510,280
0
4,432,773
4,653,587
4,653,587
4,708,888
4,804,772
5,015,368
6,451,905
6,759,091
6,914,895
5,323,263
5,727,542
5,640,007
5,246,207
5,246,2075,640,0075,727,5425,323,2636,914,8956,759,0916,451,9055,015,3684,804,7724,708,8884,653,5874,653,5874,432,77305,510,2805,510,2803,239,5003,085,5743,164,9543,643,6163,554,1703,663,7675,362,1843,659,7983,424,3633,488,9663,483,2513,024,3762,947,3732,965,8722,945,3162,915,7142,851,0322,952,1703,122,5142,953,0732,920,7192,953,2733,089,4722,841,2302,751,8872,824,7272,913,1222,707,6712,412,4062,416,6132,139,6601,982,7012,039,3131,940,7451,934,5641,921,4241,896,7721,772,9201,929,2151,679,8982,109,66601,144,0820
       Cash And Cash Equivalents 
0
239,649
0
583,792
162,615
340,586
164,968
314,640
400,600
473,327
404,988
479,157
488,277
708,777
684,597
736,904
917,704
1,079,146
797,775
788,734
891,848
1,142,500
1,007,577
807,019
900,461
895,009
737,291
750,218
815,115
886,521
846,522
668,499
582,008
1,033,792
576,712
553,697
792,134
741,982
637,697
878,406
1,033,195
579,647
380,980
397,864
0
0
0
525,094
0
547,979
425,655
523,352
484,226
529,577
448,545
2,113,221
644,942
979,780
752,817
558,691
558,691752,817979,780644,9422,113,221448,545529,577484,226523,352425,655547,9790525,094000397,864380,980579,6471,033,195878,406637,697741,982792,134553,697576,7121,033,792582,008668,499846,522886,521815,115750,218737,291895,009900,461807,0191,007,5771,142,500891,848788,734797,7751,079,146917,704736,904684,597708,777488,277479,157404,988473,327400,600314,640164,968340,586162,615583,7920239,6490
       Short-term Investments 
0
12,946
0
19,254
24,543
16,904
29,167
26,943
795
0
482
757
527
0
493
350
368
0
690
1,177
779
0
965
1,983
1,779
957
12,541
868
11,381
702
10,513
21,059
51,392
822
178,232
169,434
2,764
1,727,429
13,035
12,317
12,288
10,861
6,077
9,681
0
0
0
36,058
0
30,627
38,330
33,883
59,410
116,143
160,379
129,498
161,799
24,179
253,032
7,109
7,109253,03224,179161,799129,498160,379116,14359,41033,88338,33030,627036,0580009,6816,07710,86112,28812,31713,0351,727,4292,764169,434178,23282251,39221,05910,51370211,38186812,5419571,7791,98396507791,17769003683504930527757482079526,94329,16716,90424,54319,254012,9460
       Net Receivables 
0
282,994
0
495,450
482,080
528,595
556,479
506,722
479,529
441,788
517,776
553,504
489,891
462,655
689,852
624,488
623,536
608,328
623,945
594,071
552,286
477,803
468,114
554,882
475,214
528,518
485,251
478,038
471,385
385,265
404,251
415,744
462,839
401,573
596,716
458,962
464,280
470,495
507,617
534,973
568,294
504,200
495,777
644,698
495,476
495,476
0
772,978
754,820
754,820
884,234
865,708
908,030
810,860
998,015
935,083
1,007,363
741,430
1,039,276
1,252,407
1,252,4071,039,276741,4301,007,363935,083998,015810,860908,030865,708884,234754,820754,820772,9780495,476495,476644,698495,777504,200568,294534,973507,617470,495464,280458,962596,716401,573462,839415,744404,251385,265471,385478,038485,251528,518475,214554,882468,114477,803552,286594,071623,945608,328623,536624,488689,852462,655489,891553,504517,776441,788479,529506,722556,479528,595482,080495,4500282,9940
       Other Current Assets 
0
80,628
0
13,344
13,636
19,085
26,128
15,514
15,708
20,805
15,270
15,663
18,729
21,315
20,093
19,242
22,487
31,591
31,765
26,367
37,613
37,778
31,258
26,932
32,896
56,056
44,022
26,990
34,999
44,237
40,921
47,787
115,334
98,526
199,857
205,941
73,450
90,379
58,960
43,370
43,763
78,826
70,811
62,864
70,289
70,289
0
165,006
118,445
118,804
121,946
98,159
136,429
1,652,191
1,504,798
113,807
53,550
422,055
70,112
81,136
81,13670,112422,05553,550113,8071,504,7981,652,191136,42998,159121,946118,804118,445165,006070,28970,28962,86470,81178,82643,76343,37058,96090,37973,450205,941199,85798,526115,33447,78740,92144,23734,99926,99044,02256,05632,89626,93231,25837,77837,61326,36731,76531,59122,48719,24220,09321,31518,72915,66315,27020,80515,70815,51426,12819,08513,63613,344080,6280
   > Long-term Assets 
0
744,900
0
3,234,553
3,806,826
3,878,503
3,770,105
4,015,645
3,915,897
3,692,910
3,843,578
3,806,846
3,728,450
3,701,376
4,775,754
4,863,690
5,395,075
5,536,627
6,550,428
6,343,471
6,337,333
6,512,243
6,285,772
6,618,939
6,614,792
7,007,258
8,756,188
8,265,947
8,094,225
7,974,948
7,909,357
8,486,246
8,755,299
8,993,795
9,898,099
9,899,412
10,377,186
10,180,427
12,232,615
12,043,341
12,003,297
12,109,822
13,052,025
12,973,549
0
0
0
16,606,301
0
16,880,390
16,641,942
16,627,972
17,049,130
15,002,765
15,193,919
15,376,559
14,960,381
15,677,699
15,338,550
14,520,952
14,520,95215,338,55015,677,69914,960,38115,376,55915,193,91915,002,76517,049,13016,627,97216,641,94216,880,390016,606,30100012,973,54913,052,02512,109,82212,003,29712,043,34112,232,61510,180,42710,377,1869,899,4129,898,0998,993,7958,755,2998,486,2467,909,3577,974,9488,094,2258,265,9478,756,1887,007,2586,614,7926,618,9396,285,7726,512,2436,337,3336,343,4716,550,4285,536,6275,395,0754,863,6904,775,7543,701,3763,728,4503,806,8463,843,5783,692,9103,915,8974,015,6453,770,1053,878,5033,806,8263,234,5530744,9000
       Property Plant Equipment 
0
434,131
0
639,735
868,331
775,869
772,513
823,251
809,060
810,107
835,705
840,880
826,604
840,238
942,446
999,201
1,077,813
1,147,782
1,575,917
1,559,928
1,582,389
1,644,402
1,606,963
1,659,780
1,680,447
1,809,852
1,841,190
1,775,907
1,740,630
1,760,053
1,728,516
1,819,289
1,868,809
1,951,983
1,995,589
2,680,255
2,112,661
2,863,403
2,209,941
2,911,500
2,173,983
3,002,803
2,423,071
3,135,099
3,343,154
3,343,154
0
4,227,930
4,168,489
4,168,489
3,220,428
3,225,684
3,278,650
4,192,363
3,249,983
4,214,569
3,162,439
4,310,150
3,241,111
4,036,360
4,036,3603,241,1114,310,1503,162,4394,214,5693,249,9834,192,3633,278,6503,225,6843,220,4284,168,4894,168,4894,227,93003,343,1543,343,1543,135,0992,423,0713,002,8032,173,9832,911,5002,209,9412,863,4032,112,6612,680,2551,995,5891,951,9831,868,8091,819,2891,728,5161,760,0531,740,6301,775,9071,841,1901,809,8521,680,4471,659,7801,606,9631,644,4021,582,3891,559,9281,575,9171,147,7821,077,813999,201942,446840,238826,604840,880835,705810,107809,060823,251772,513775,869868,331639,7350434,1310
       Goodwill 
0
189,448
0
0
0
1,895,101
1,836,684
1,950,389
1,905,820
1,869,899
1,925,703
1,937,064
1,879,973
1,829,141
2,748,241
2,779,267
3,089,570
3,174,732
3,574,483
3,440,974
3,434,748
3,532,359
3,381,398
3,464,745
3,446,734
3,643,995
0
5,023,903
0
4,590,498
0
4,993,142
0
5,209,230
0
5,416,606
0
5,507,063
0
5,501,972
0
5,332,271
0
5,988,765
0
0
0
7,847,911
0
7,011,909
0
6,898,821
0
6,802,127
0
7,101,997
0
7,403,056
0
6,858,103
6,858,10307,403,05607,101,99706,802,12706,898,82107,011,90907,847,9110005,988,76505,332,27105,501,97205,507,06305,416,60605,209,23004,993,14204,590,49805,023,90303,643,9953,446,7343,464,7453,381,3983,532,3593,434,7483,440,9743,574,4833,174,7323,089,5702,779,2672,748,2411,829,1411,879,9731,937,0641,925,7031,869,8991,905,8201,950,3891,836,6841,895,101000189,4480
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
232,421
307,941
268,879
295,103
259,063
330,171
228,262
238,504
228,820
366,980
267,653
264,308
143,984
2,089,839
2,071,069
2,039,351
2,067,177
2,129,789
2,136,964
0
0
0
2,554,608
0
2,443,078
0
2,536,044
2,597,295
565,105
0
559,998
690,097
528,972
0
471,009
471,0090528,972690,097559,9980565,1052,597,2952,536,04402,443,07802,554,6080002,136,9642,129,7892,067,1772,039,3512,071,0692,089,839143,984264,308267,653366,980228,820238,504228,262330,171259,063295,103268,879307,941232,4210000000000000000000000000
       Intangible Assets 
0
78,299
0
0
0
1,008,307
971,901
1,038,977
1,000,746
969,095
989,745
974,645
949,631
946,435
982,524
984,153
1,048,567
1,068,361
1,193,813
1,149,060
1,138,643
1,161,572
1,107,712
1,139,126
1,130,970
1,195,302
6,529,475
1,101,789
5,972,107
1,269,342
5,789,588
1,342,527
6,580,700
1,385,537
7,414,608
1,417,377
7,880,443
1,433,534
0
1,433,768
0
1,557,650
0
1,570,576
0
0
0
1,736,913
0
2,949,147
10,646,785
3,747,955
0
2,832,196
10,741,139
2,880,924
10,654,352
2,926,132
11,225,180
2,740,576
2,740,57611,225,1802,926,13210,654,3522,880,92410,741,1392,832,19603,747,95510,646,7852,949,14701,736,9130001,570,57601,557,65001,433,76801,433,5347,880,4431,417,3777,414,6081,385,5376,580,7001,342,5275,789,5881,269,3425,972,1071,101,7896,529,4751,195,3021,130,9701,139,1261,107,7121,161,5721,138,6431,149,0601,193,8131,068,3611,048,567984,153982,524946,435949,631974,645989,745969,0951,000,7461,038,977971,9011,008,30700078,2990
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
196,308
77,582
95,469
86,385
328,337
61,082
103,026
67,286
505,430
120,922
224,468
119,774
564,251
131,545
254,449
126,396
812,555
142,002
232,391
882,614
882,614
0
344,972
1,930,408
1,930,408
197,837
219,468
0
0
0
0
0
0
0
0
00000000219,468197,8371,930,4081,930,408344,9720882,614882,614232,391142,002812,555126,396254,449131,545564,251119,774224,468120,922505,43067,286103,02661,082328,33786,38595,46977,582196,3080000000000000000000000000
> Total Liabilities 
0
1,181,592
0
3,830,625
3,888,114
4,142,724
3,858,297
4,074,583
3,983,199
3,746,733
3,826,135
3,901,399
3,741,961
3,733,832
4,967,995
5,038,472
5,563,079
5,786,861
6,239,855
6,021,473
5,975,546
6,300,325
5,941,610
6,127,307
6,035,427
6,401,794
7,891,593
7,532,149
7,421,824
7,286,299
7,165,384
7,462,375
7,632,305
7,780,442
8,510,000
8,437,956
8,745,110
8,696,843
8,689,846
8,556,735
8,538,992
8,554,721
8,940,868
9,275,958
0
0
0
12,619,686
0
13,076,433
13,175,625
13,209,179
13,495,808
13,468,378
13,831,216
13,982,305
12,288,584
12,798,216
12,684,665
12,169,006
12,169,00612,684,66512,798,21612,288,58413,982,30513,831,21613,468,37813,495,80813,209,17913,175,62513,076,433012,619,6860009,275,9588,940,8688,554,7218,538,9928,556,7358,689,8468,696,8438,745,1108,437,9568,510,0007,780,4427,632,3057,462,3757,165,3847,286,2997,421,8247,532,1497,891,5936,401,7946,035,4276,127,3075,941,6106,300,3255,975,5466,021,4736,239,8555,786,8615,563,0795,038,4724,967,9953,733,8323,741,9613,901,3993,826,1353,746,7333,983,1994,074,5833,858,2974,142,7243,888,1143,830,62501,181,5920
   > Total Current Liabilities 
0
423,126
0
962,930
555,483
646,077
660,812
677,890
641,208
592,865
611,595
742,411
656,592
715,296
743,392
796,993
985,538
1,079,711
1,000,248
1,005,317
975,446
1,053,006
893,200
975,191
925,678
1,071,763
944,838
900,321
952,067
977,987
948,036
1,015,690
1,086,420
1,257,321
1,215,110
1,276,459
1,394,814
1,366,558
1,333,835
1,240,627
1,244,510
1,335,138
1,560,858
1,921,478
3,474,312
3,474,312
0
1,656,330
1,955,847
1,955,847
2,041,284
1,876,984
2,025,059
2,315,604
3,038,364
4,111,962
2,355,575
2,156,146
2,170,219
1,990,152
1,990,1522,170,2192,156,1462,355,5754,111,9623,038,3642,315,6042,025,0591,876,9842,041,2841,955,8471,955,8471,656,33003,474,3123,474,3121,921,4781,560,8581,335,1381,244,5101,240,6271,333,8351,366,5581,394,8141,276,4591,215,1101,257,3211,086,4201,015,690948,036977,987952,067900,321944,8381,071,763925,678975,191893,2001,053,006975,4461,005,3171,000,2481,079,711985,538796,993743,392715,296656,592742,411611,595592,865641,208677,890660,812646,077555,483962,9300423,1260
       Short-term Debt 
0
194,915
0
509,726
121,650
150,224
184,689
208,115
184,444
192,003
187,829
234,971
228,189
251,389
154,638
175,853
175,730
165,860
177,826
169,738
200,192
186,797
193,944
191,939
204,761
203,944
158,813
129,333
170,557
133,067
174,405
192,648
247,568
10,427
329,969
328,564
415,426
320,802
331,406
260,059
319,916
319,571
637,112
899,517
0
0
0
401,283
0
681,273
761,319
655,165
757,246
897,915
1,745,272
2,677,713
1,016,882
639,661
657,299
393,970
393,970657,299639,6611,016,8822,677,7131,745,272897,915757,246655,165761,319681,2730401,283000899,517637,112319,571319,916260,059331,406320,802415,426328,564329,96910,427247,568192,648174,405133,067170,557129,333158,813203,944204,761191,939193,944186,797200,192169,738177,826165,860175,730175,853154,638251,389228,189234,971187,829192,003184,444208,115184,689150,224121,650509,7260194,9150
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,905,583
6,491,862
6,148,992
170,557
129,122
174,405
188,757
247,568
257,772
329,969
289,133
415,426
276,397
0
215,445
0
276,929
0
854,202
0
0
0
338,987
0
578,917
0
0
0
790,814
0
2,568,853
0
523,127
0
282,141
282,1410523,12702,568,8530790,814000578,9170338,987000854,2020276,9290215,4450276,397415,426289,133329,969257,772247,568188,757174,405129,122170,5576,148,9926,491,8624,905,5830000000000000000000000000
       Accounts payable 
0
160,678
0
292,011
0
280,722
302,285
277,635
268,966
228,405
219,377
241,198
241,825
273,621
369,300
370,755
393,078
439,631
381,341
367,794
351,816
409,986
379,996
400,542
390,979
461,073
786,025
394,821
0
423,096
0
427,194
0
561,883
0
536,743
0
581,882
0
551,905
0
601,618
0
580,247
628,992
628,992
0
701,158
731,918
731,918
0
708,970
0
813,114
0
877,723
0
852,305
0
878,681
878,6810852,3050877,7230813,1140708,9700731,918731,918701,1580628,992628,992580,2470601,6180551,9050581,8820536,7430561,8830427,1940423,0960394,821786,025461,073390,979400,542379,996409,986351,816367,794381,341439,631393,078370,755369,300273,621241,825241,198219,377228,405268,966277,635302,285280,7220292,0110160,6780
       Other Current Liabilities 
0
63,361
0
133,966
433,833
210,440
163,305
160,370
140,180
157,462
161,509
176,536
180,111
167,219
179,431
199,968
357,307
339,602
340,554
370,541
383,985
400,563
294,942
350,009
307,979
358,037
786,025
355,231
781,510
372,259
773,631
375,570
1,086,420
632,316
885,141
370,395
979,388
399,597
1,002,429
359,420
924,594
361,800
923,746
412,179
123,594
123,594
0
477,287
228,342
470,016
1,279,965
483,919
1,267,813
550,859
1,293,092
505,513
1,338,693
508,329
1,512,920
631,434
631,4341,512,920508,3291,338,693505,5131,293,092550,8591,267,813483,9191,279,965470,016228,342477,2870123,594123,594412,179923,746361,800924,594359,4201,002,429399,597979,388370,395885,141632,3161,086,420375,570773,631372,259781,510355,231786,025358,037307,979350,009294,942400,563383,985370,541340,554339,602357,307199,968179,431167,219180,111176,536161,509157,462140,180160,370163,305210,440433,833133,966063,3610
   > Long-term Liabilities 
0
758,466
0
2,867,695
3,332,631
3,496,647
3,197,485
3,396,693
3,341,991
3,153,868
3,214,540
3,158,988
3,085,369
3,018,536
4,224,603
4,241,479
4,577,541
4,707,150
5,239,607
5,016,156
5,000,100
5,247,319
5,048,410
5,152,116
5,109,749
5,330,031
6,946,755
6,631,828
6,469,757
6,308,312
6,217,348
6,446,685
6,545,885
6,523,121
7,294,890
7,161,497
7,350,296
7,330,285
7,356,011
7,316,108
7,294,482
7,219,583
7,380,010
7,354,480
0
0
0
10,963,356
0
11,120,586
11,134,341
11,332,195
11,470,749
11,152,774
10,792,852
9,870,343
9,933,009
10,642,070
10,514,446
10,178,854
10,178,85410,514,44610,642,0709,933,0099,870,34310,792,85211,152,77411,470,74911,332,19511,134,34111,120,586010,963,3560007,354,4807,380,0107,219,5837,294,4827,316,1087,356,0117,330,2857,350,2967,161,4977,294,8906,523,1216,545,8856,446,6856,217,3486,308,3126,469,7576,631,8286,946,7555,330,0315,109,7495,152,1165,048,4105,247,3195,000,1005,016,1565,239,6074,707,1504,577,5414,241,4794,224,6033,018,5363,085,3693,158,9883,214,5403,153,8683,341,9913,396,6933,197,4853,496,6473,332,6312,867,6950758,4660
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,155,001
0
0
9,998,562
9,372,970
0
0
0
0
0
0
0
0
000000009,372,9709,998,562009,155,00100000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
648,935
613,706
612,169
580,302
430,134
389,914
490,800
430,027
502,613
430,730
499,437
446,719
544,198
492,373
533,082
566,296
627,755
649,057
648,372
682,364
682,364
0
1,808,355
2,051,734
2,051,734
0
0
0
0
0
0
0
0
0
0
00000000002,051,7342,051,7341,808,3550682,364682,364648,372649,057627,755566,296533,082492,373544,198446,719499,437430,730502,613430,027490,800389,914430,134580,302612,169613,706648,9350000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
70,620
0
0
0
232,345
0
0
0
287,205
0
0
0
331,808
0
0
0
575,515
0
0
633,240
633,240
0
0
1,622,641
1,622,641
0
0
0
0
0
0
0
0
0
0
00000000001,622,6411,622,64100633,240633,24000575,515000331,808000287,205000232,34500070,6200000000000000000000000000
> Total Stockholder Equity
0
693,040
0
1,500,653
1,596,238
1,662,507
1,682,267
1,831,277
1,849,945
1,876,768
1,955,489
1,936,921
1,962,506
2,101,262
2,219,681
2,231,612
2,534,163
2,658,123
3,131,093
3,070,151
3,198,391
3,296,203
3,292,597
3,408,203
3,528,399
3,721,481
3,810,432
3,579,042
3,582,689
3,629,079
3,705,408
3,967,400
4,145,026
4,225,554
4,401,149
4,393,764
4,771,872
4,822,119
5,543,509
5,364,941
5,347,090
5,108,392
5,423,090
5,168,166
0
0
0
6,329,834
0
6,129,938
5,852,832
5,861,818
6,127,078
5,827,166
5,943,740
5,592,707
5,349,895
5,883,727
5,639,456
5,169,080
5,169,0805,639,4565,883,7275,349,8955,592,7075,943,7405,827,1666,127,0785,861,8185,852,8326,129,93806,329,8340005,168,1665,423,0905,108,3925,347,0905,364,9415,543,5094,822,1194,771,8724,393,7644,401,1494,225,5544,145,0263,967,4003,705,4083,629,0793,582,6893,579,0423,810,4323,721,4813,528,3993,408,2033,292,5973,296,2033,198,3913,070,1513,131,0932,658,1232,534,1632,231,6122,219,6812,101,2621,962,5061,936,9211,955,4891,876,7681,849,9451,831,2771,682,2671,662,5071,596,2381,500,6530693,0400
   Common Stock
0
0
0
114,914
114,914
117,882
117,882
117,882
117,882
1,008,237
1,009,870
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
119,604
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
1,030,332
119,604
119,604
0
1,030,332
119,604
119,604
119,604
1,030,332
119,604
119,604
119,604
119,604
119,604
119,604
119,604
119,604
119,604119,604119,604119,604119,604119,604119,604119,6041,030,332119,604119,604119,6041,030,3320119,604119,6041,030,3321,030,3321,030,3321,030,3321,030,3321,030,332119,6041,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,030,3321,009,8701,008,237117,882117,882117,882117,882114,914114,914000
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
352,871
0
-91,640
549,103
627,074
-10,136
72,410
27,231
614,905
943,526
881,453
822,801
794,134
1,137,131
1,020,805
1,226,174
1,312,734
2,127,467
1,836,889
1,825,025
1,911,916
2,313,528
2,175,453
2,160,681
2,337,311
2,837,725
2,333,271
2,183,016
2,121,455
2,710,096
2,673,530
2,701,838
2,790,768
3,448,635
3,126,202
3,367,722
3,353,053
4,512,732
4,296,960
4,011,637
3,503,248
4,330,055
4,035,208
0
0
0
5,314,614
0
5,053,547
4,984,720
5,046,399
5,252,116
4,949,582
5,044,737
4,671,403
4,376,898
4,782,162
4,681,568
4,094,130
4,094,1304,681,5684,782,1624,376,8984,671,4035,044,7374,949,5825,252,1165,046,3994,984,7205,053,54705,314,6140004,035,2084,330,0553,503,2484,011,6374,296,9604,512,7323,353,0533,367,7223,126,2023,448,6352,790,7682,701,8382,673,5302,710,0962,121,4552,183,0162,333,2712,837,7252,337,3112,160,6812,175,4532,313,5281,911,9161,825,0251,836,8892,127,4671,312,7341,226,1741,020,8051,137,131794,134822,801881,453943,526614,90527,23172,410-10,136627,074549,103-91,6400352,8710
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
910,728
0
0
910,728
910,728
0
0
0
0
0
0
0
0
00000000910,728910,72800910,72800000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
224,656
0
938,322
888,428
888,428
888,426
937,642
888,426
887,295
801,446
821,819
821,819
910,728
910,728
866,368
849,400
841,476
841,476
852,153
852,153
852,153
853,834
848,703
842,018
842,018
842,018
848,306
848,306
848,306
855,287
855,287
855,287
855,287
855,287
861,078
861,144
861,144
861,621
866,958
866,994
866,994
843,496
746,539
4,988,419
4,988,419
0
751,967
5,004,515
748,508
748,508
752,036
752,036
757,980
757,980
765,441
765,441
776,280
778,560
778,560
778,560778,560776,280765,441765,441757,980757,980752,036752,036748,508748,5085,004,515751,96704,988,4194,988,419746,539843,496866,994866,994866,958861,621861,144861,144861,078855,287855,287855,287855,287855,287848,306848,306848,306842,018842,018842,018848,703853,834852,153852,153852,153841,476841,476849,400866,368910,728910,728821,819821,819801,446887,295888,426937,642888,426888,428888,428938,3220224,6560



6.3. Balance Sheets

Currency in EUR. All numbers in thousands.




6.4. Cash Flows

Currency in EUR. All numbers in thousands.




6.5. Income Statements

Currency in EUR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in EUR. All numbers in thousands.

Gross Profit (+$)
totalRevenue7,212,382
Cost of Revenue-4,364,683
Gross Profit2,847,6992,847,699
 
Operating Income (+$)
Gross Profit2,847,699
Operating Expense-1,655,684
Operating Income1,192,0151,192,015
 
Operating Expense (+$)
Research Development384,036
Selling General Administrative1,144,011
Selling And Marketing Expenses0
Operating Expense1,655,6841,528,047
 
Net Interest Income (+$)
Interest Income44,423
Interest Expense-714,765
Other Finance Cost-30,782
Net Interest Income-701,124
 
Pretax Income (+$)
Operating Income1,192,015
Net Interest Income-701,124
Other Non-Operating Income Expenses0
Income Before Tax (EBT)443,9961,940,034
EBIT - interestExpense = 604,754
388,110
871,685
Interest Expense714,765
Earnings Before Interest and Taxes (EBIT)1,319,5191,158,761
Earnings Before Interest and Taxes (EBITDA)1,608,263
 
After tax Income (+$)
Income Before Tax443,996
Tax Provision-231,190
Net Income From Continuing Ops212,806212,806
Net Income156,920
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses6,020,367
Total Other Income/Expenses Net-748,019701,124
 

Technical Analysis of Grifols
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Grifols. The general trend of Grifols is BULLISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Grifols's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (42.9%) Bearish trend (-42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Grifols Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Grifols S.A..

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 12.50 < 13.00 < 13.71.

The bearish price targets are: 11.79 > 11.03 > 10.83.

Know someone who trades $GRF? Share this with them.πŸ‘‡

Grifols S.A. Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Grifols S.A.. The current mas is .

The long score for the Moving Averages is 10/14.
The longshort score for the Moving Averages is 6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Grifols S.A. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Grifols S.A.. The current macd is -0.05358419.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Grifols price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Grifols. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Grifols price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Grifols S.A. Daily Moving Average Convergence/Divergence (MACD) ChartGrifols S.A. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Grifols S.A.. The current adx is 16.14.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Grifols shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Grifols S.A. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Grifols S.A.. The current sar is 12.46.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Grifols S.A. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Grifols S.A.. The current rsi is 42.47. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Grifols S.A. Daily Relative Strength Index (RSI) ChartGrifols S.A. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Grifols S.A.. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Grifols price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Grifols S.A. Daily Stochastic Oscillator ChartGrifols S.A. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Grifols S.A.. The current cci is -115.66145446.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Grifols S.A. Daily Commodity Channel Index (CCI) ChartGrifols S.A. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Grifols S.A.. The current cmo is -24.53136327.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Grifols S.A. Daily Chande Momentum Oscillator (CMO) ChartGrifols S.A. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Grifols S.A.. The current willr is -83.8028169.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Grifols S.A. Daily Williams %R ChartGrifols S.A. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Grifols S.A..

Grifols S.A. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Grifols S.A.. The current atr is 0.25406654.

Grifols S.A. Daily Average True Range (ATR) ChartGrifols S.A. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Grifols S.A.. The current obv is -10,920,963.

Grifols S.A. Daily On-Balance Volume (OBV) ChartGrifols S.A. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Grifols S.A.. The current mfi is 38.03.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Grifols S.A. Daily Money Flow Index (MFI) ChartGrifols S.A. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Grifols S.A..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-05-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-09WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-04CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-23STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-07-16STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-18MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-07-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-07-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-31STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-08-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-14STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-01STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-09-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Grifols S.A. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Grifols S.A. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.466
Ma 20Greater thanMa 5012.140
Ma 50Greater thanMa 10012.307
Ma 100Greater thanMa 20011.042
OpenGreater thanClose12.065
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Grifols with someone you think should read this too:
  • Are you bullish or bearish on Grifols? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Grifols? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Grifols S.A.

I send you an email if I find something interesting about Grifols S.A..


Comments

How you think about this?

Leave a comment

Stay informed about Grifols S.A..

Receive notifications about Grifols S.A. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.